US EditionMiRus Siegel™ TAVR: First EFS Cases
- MiRus launched a multi-center Early Feasibility Study of the Siegel 8-Fr aortic transcatheter heart valve in the US.
- The first two cases were successfully performed by Pradeep K. Yadav and Vinod H. Thourani, with both patients discharged the next day without complications.
- The Siegel valve features an 8 French delivery sheath and is the only Nickel-free transcatheter heart valve for patients with Nickel allergies.
- Both doctors reported positive initial experiences, highlighting the valve's precise placement and excellent hemodynamics.
Insights by Ground AI
Does this summary seem wrong?
19 Articles
19 Articles
All
Left
2
Center
3
Right
2
Brunswicktimes Gazette+18 Reposted by 18 other sources
MiRus Siegel™ TAVR: First EFS Cases
ATLANTA, March 28, 2025 /PRNewswire/ -- MiRus is pleased to announce the launch of the US multi-center Early Feasibility Study of the Siegel™ 8-Fr aortic transcatheter heart valve (THV). The first two cases were successfully performed this week by Pradeep…
·Lawrenceville, United States
Read Full ArticleCoverage Details
Total News Sources19
Leaning Left2Leaning Right2Center3Last UpdatedBias Distribution43% Center
Bias Distribution
- 43% of the sources are Center
43% Center
L 29%
C 43%
R 29%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
